Migraine News and Research

Latest Migraine News and Research

People with early Parkinson's frequently experience many non-motor symptoms

While movement problems are the main symptom of Parkinson's disease, a new study shows that even early in the course of disease people frequently experience many non-motor symptoms such as drooling, anxiety and constipation.

16 Jan 2013

Saliva gland test shows promise for Parkinson's

New research suggests that testing a portion of a person's saliva gland may be a way to diagnose Parkinson's disease.

11 Jan 2013

Apparent stem cell transplant success in mice may hold promise for people with ALS

Apparent stem cell transplant success in mice may hold promise for people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.

11 Jan 2013

Epilepsy, migraine susceptibility kept in the family

Researchers report that there is a shared genetic susceptibility to epilepsy and migraine with aura.

9 Jan 2013

Dopamine-related drug exposure, Parkinson's increase risk of impulse control problems

Parkinson's disease itself does not increase the risk of impulse control problems such as compulsive gambling and shopping that have been seen in people taking certain drugs for Parkinson's disease, according to new research published in the January 8, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.

9 Jan 2013

Beta blockers can reduce risk of Alzheimer's, other types of dementia

People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

9 Jan 2013

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.

7 Jan 2013

New research reveals a shared genetic susceptibility to epilepsy and migraine

New research reveals a shared genetic susceptibility to epilepsy and migraine. Findings published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), indicate that having a strong family history of seizure disorders increases the chance of having migraine with aura (MA).

7 Jan 2013

Researchers discover new pathway to reduce paradoxical pain

For individuals with agonizing pain, it is a cruel blow when the gold-standard medication actually causes more pain. Adults and children whose pain gets worse when treated with morphine may be closer to a solution, based on research published in the January 6 on-line edition of Nature Neuroscience.

7 Jan 2013

Electroconvulsive therapy releases opiate-like substances

Researchers used electricity on certain regions in the brain of a patient with chronic, severe facial pain to release an opiate-like substance that's considered one of the body's most powerful painkillers.

3 Jan 2013

New cost-effective, less invasive MRI method for diagnosis of dementia

A new way to use MRI scans may help determine whether dementia is Alzheimer's disease or another type of dementia, according to new research published in the December 26, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Dec 2012

Transcranial stimulation improves symptoms of Tourette’s

A month of daily transcranial magnetic stimulation targeting the supplemental motor area results in lasting improvements in symptoms of Tourette syndrome, show study findings.

18 Dec 2012

Two UT Southwestern researchers to receive 2013 Edith and Peter O'Donnell Award

The Academy of Medicine, Engineering, and Science of Texas (TAMEST) announced that two UT Southwestern Medical Center researchers are among the four chosen for the 2013 Edith and Peter O'Donnell Awards.

12 Dec 2012

RedHill Biopharma completes $6.5M private placement

RedHill Biopharma Ltd., an Israeli biopharmaceutical company focusing primarily on development and acquisition of late clinical stage, patent-protected, new formulations and combinations of existing drugs, reported the completion of a private placement in a total amount of approximately $6.5 million.

6 Dec 2012

Tips to prevent holiday headaches

Holidays are a time for family, friends, and happy memories. But those joyful moments can be associated with stress – from marathon shopping, preparing for celebrations, and traveling. Stress and other stimuli may trigger or increase your headaches.

30 Nov 2012

Suvorexant may bring help for people with insomnia

A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Nov 2012

FDA accepts MAP Pharmaceuticals’ resubmission of NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).

22 Nov 2012

New AAN book for people with primary and metastatic brain tumors

It is estimated that every 30 minutes, someone is diagnosed with brain cancer. Published in conjunction with the American Academy of Neurology as part of the Neurology Now Books series, NAVIGATING LIFE WITH A BRAIN TUMOR provides readily accessible information and encouragement for the thousands of people living with primary and metastatic brain tumors.

16 Nov 2012

Women with migraines do not appear to experience cognitive decline

Women with migraines did not appear to experience a decline in cognitive ability over time compared to those who didn't have them, according to a nine-year follow up study funded by the National Institutes of Health.

13 Nov 2012

Children with migraine more likely to have below average school performance

Children with migraine are more likely to have below average school performance than kids who do not have headaches, according to new research published in the October 30, 2012, print issue of Neurology-, the medical journal of the American Academy of Neurology.

30 Oct 2012

Migraine News and Research

Latest Migraine News and Research

People with early Parkinson's frequently experience many non-motor symptoms

Saliva gland test shows promise for Parkinson's

Apparent stem cell transplant success in mice may hold promise for people with ALS

Epilepsy, migraine susceptibility kept in the family

Dopamine-related drug exposure, Parkinson's increase risk of impulse control problems

Beta blockers can reduce risk of Alzheimer's, other types of dementia

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

New research reveals a shared genetic susceptibility to epilepsy and migraine

Researchers discover new pathway to reduce paradoxical pain

Electroconvulsive therapy releases opiate-like substances

New cost-effective, less invasive MRI method for diagnosis of dementia

Transcranial stimulation improves symptoms of Tourette’s

Two UT Southwestern researchers to receive 2013 Edith and Peter O'Donnell Award

RedHill Biopharma completes $6.5M private placement

Tips to prevent holiday headaches

Suvorexant may bring help for people with insomnia

FDA accepts MAP Pharmaceuticals’ resubmission of NDA for LEVADEX

New AAN book for people with primary and metastatic brain tumors

Women with migraines do not appear to experience cognitive decline

Children with migraine more likely to have below average school performance

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Migraine News and Research

Latest Migraine News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in